Status:
RECRUITING
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
Lead Sponsor:
University of Leicester
Collaborating Sponsors:
University Hospitals, Leicester
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
40-74 years
Brief Summary
The Genetics and Vascular Health Check study (GENVASC) is a large study run in conjunction with Clinical Commissioning Groups and Primary Care practices across Leicester, Leicestershire and Northampto...
Detailed Description
Coronary Artery Disease (CAD) is the commonest cause of premature death and disability in the UK. Several demographic and lifestyle factors, such as age, gender, smoking, hypertension, diabetes and dy...
Eligibility Criteria
Inclusion
- Male and female patients who are eligible for an NHS Health Check
- Aged between 40 and 74 years of age
- Able to provide informed consent
Exclusion
- History of preexisting cardiovascular disease
- History of blood borne infection (such as HIV, Hepatitis B)
- Unable to provide informed consent
Key Trial Info
Start Date :
September 9 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2027
Estimated Enrollment :
30000 Patients enrolled
Trial Details
Trial ID
NCT04417387
Start Date
September 9 2012
End Date
March 31 2027
Last Update
November 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Primary Care, LLR and Northamptonshire
Leicester, United Kingdom